The Unexpected Guardians of AI Governance

When we think of artificial intelligence governance, we usually picture government hearings, bureaucratic red tape, or Silicon Valley boardrooms. We rarely think of religious encyclicals or shareholder proxy votes. Yet, a fascinating narrative is emerging that connects the two, highlighting a new frontline in the battle for ethical AI.

The recently discussed encyclical Magnifica Humanitas ("Magnificent Humanity") introduces a blunt reality check to the tech industry: "Technology is never neutral." For too long, AI has been marketed as an inevitable force of nature or a hyper-rational, objective tool. In reality, it is a commercial product controlled by a shrinking number of powerful corporate entities.

The text frames our current technological moment as a choice between two ancient paths. One is the Tower of Babel—representing relentless, unchecked growth divorced from human cost, ultimately leading to societal atomization. The other is a path of collaborative resilience, where shared responsibility takes precedence over isolated ambition.

This philosophical framing becomes urgently practical when we look at the current state of global regulation. A massive governance vacuum exists. The US Federal Trade Commission possesses limited authority over algorithmic design, guidelines from the National Institute of Standards and Technology are largely voluntary, and the EU AI Act covers only specific deployment areas. AI systems are being rolled out at scale with alarmingly little institutional oversight.

Stepping into this void are institutional investors. Managing hundreds of billions of dollars in assets, coalitions like the Interfaith Center on Corporate Responsibility are using their financial leverage to demand transparency, risk assessment, and ethical boundaries. They are treating AI governance failures not just as moral lapses, but as material business risks.

This shareholder activism spans multiple critical sectors. Investors have challenged healthcare giants like CVS and UnitedHealth to ensure AI doesn't compromise patient care or healthcare quality. They have confronted Meta and Microsoft over the massive energy and water consumption of their AI data centers, which carry heavy environmental footprints. In Hollywood, shareholders at Disney, Netflix, and Warner Bros. are demanding transparency to protect the irreplaceable human element in creative storytelling. Furthermore, tech giants like Alphabet and Palantir face pressure to ensure their algorithms are not weaponized or used to violate human rights.

As private AI labs like OpenAI and Anthropic eventually eye public markets, the power of the shareholder will only grow. The actions of these investors remind us that we are not powerless in the face of technological upheaval. By treating AI as a societal project rather than just a technological race, we can use every tool at our disposal—including our investment portfolios—to ensure AI serves our shared humanity.

Key Points

• Technology is not neutral; AI is a commercial product shaped by concentrated corporate power rather than an objective force of nature.
• With government regulations lagging globally, a significant governance vacuum exists in the AI sector.
• Institutional investors are leveraging billions of dollars in assets to force companies like Microsoft, Disney, and CVS to adopt ethical AI practices.

Why It Matters

As AI reshapes society, recognizing that financial markets can be leveraged for ethical oversight empowers the public to demand accountability beyond traditional government regulation.

Sources:

• How the Pope’s Magnifica Humanitas offers a template for individuals to meet the AI moment — MIT Technology Review - AI